Pedro Huertas Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pedro Huertas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Pedro Huertas. Pedro Huertas is a Chief Medical Officer in Eloxx Pharmaceuticals, Inc. ($SVON) and a Chief Development Officer in Ocata Therapeutics, Inc. ($ACTC) and a See Remarks in Inozyme Pharma, Inc. ($INZY) and a SVP, CMO in Inozyme Pharma, Inc. ($INZY).
Address: 283 SIMON WILLARD ROAD CONCORD 01742 MA
Companies in which Pedro Huertas is an Insider
Eloxx Pharmaceuticals, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Pedro Huertas: Chief Medical Officer
Holdings: 137,725 shares
Current Value: $31,677
Latest Transaction: May 18 2018
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Pedro Huertas: SVP, CMO, See Remarks
Holdings: 0 shares
Latest Transaction: Jan 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Pedro Huertas: Chief Development Officer
Holdings: 0 shares
Latest Transaction: Sep 10 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Pedro Huertas
Sentiment: All, ELOX, INZY, ACTC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Huertas Pedro | SVP, CMO | Option Exercise | A | 2.77 | 36,074 | 99,925 | 36,074 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Huertas Pedro | See Remarks | Option Exercise | A | 16.00 | 43,951 | 703,216 | 43,951 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Huertas Pedro | See Remarks | Option Exercise | A | 16.00 | 43,951 | 703,216 | 43,951 | |
| May 18 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Grant | A | 0.00 | 33,000 | 0 | 137,725 | 104.7 K to 137.7 K (+31.51 %) |
| May 11 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Option Exercise | A | 14.88 | 104,725 | 1,558,308 | 104,725 | |
| May 11 2018 | ELOX | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Grant | A | 0.00 | 104,725 | 0 | 104,725 | 0 to 104.7 K |
| Jan 22 2018 | SVON | Eloxx Pharmaceutic ... | Huertas Pedro | Chief Medical Offic ... | Option Exercise | A | 6.65 | 50,000 | 332,500 | 50,000 |